Chim C. Lang

Activation of Neutrophil Extracellular Trap Formation in Patients with Heart Failure and a Preserved Ejection Fraction

Protein biomarkers associated with left bundle branch block in patients with heart failure and reduced ejection fraction.

Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease: An Exploratory Analysis of the SELECT Randomized Clinical Trial.

Heart Failure in Type 1 vs. Type 2 Diabetes Mellitus: Shared Pathways, Distinct Challenges.

Decoding the Heart Failure Peptidome.

Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis: The EVOLVED Randomized Clinical Trial.

Genome-wide association study meta-analysis provides insights into the etiology of heart failure and its subtypes

Interdisciplinary perspectives on the co-management of metabolic dysfunction-associated steatotic liver disease and coronary artery disease.

Deep-learning prediction of cardiovascular outcomes from routine retinal images in individuals with type 2 diabetes.

Circulating bone morphogenetic protein 10 as a novel marker of atrial stress and remodelling in heart failure.

Time-varying cost-effectiveness analysis of sodium-glucose cotransporter-2 inhibitors in Chinese patients with heart failure and reduced ejection fraction: A microsimulation of the real-world population.

Use of an extensively humanized mouse model to predict the risk of drug-drug interactions in patients receiving dexamethasone.

Effect of Frailty on Cardiovascular Clinical Trials: A Systematic Review and Meta-Analysis.

Distinct Genetic Risk Profile in Aortic Stenosis Compared With Coronary Artery Disease.

Dapagliflozin reduces epicardial adipose tissue in patients with heart failure and type 2 diabetes.

Inpatient versus outpatient diagnosis of heart failure across the spectrum of ejection fraction: a population cohort study.

Guideline-directed medical strategies for the co-management of heart failure and metabolic dysfunction-associated steatotic liver disease.

The transcriptional profile of iron deficiency in patients with heart failure: Heme-sparing and reduced immune processes.

Resistance Exercise Therapy After COVID-19 Infection: A Randomized Clinical Trial.

Blood Urea/Creatinine Ratio and Mortality in Ambulatory Patients with Heart Failure with Reduced Ejection Fraction.

Clinical effectiveness and cost-effectiveness of the rehabilitation enablement in chronic heart failure facilitated self-care rehabilitation intervention for people with heart failure with preserved ejection fraction and their caregivers: rationale and protocol for a multicentre randomised controlled trial - REACH-HFpEF trial.

Genetics of type 2 diabetes (T2D) in Malaysia: a review

Understanding the self-management experiences of people with heart failure with preserved ejection fraction (HFpEF), their caregivers and the health care professionals who support them: Systematic review and qualitative meta-study.

Emerging imaging and circulating biomarkers in relation to underlying mechanisms in Bicuspid Aortic Valve aortopathy.

SGLT Inhibitors in Persons With Heart Failure and Type 1 Diabetes: Filling the Therapeutic Gap.

Far infrared therapy improves vascular function by enhancing endothelial function and decreasing arterial stiffness via cytoprotective pathways.

N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP)-A Prognostic Biomarker in Older and/or Frail Adults with Advanced Gastroesophageal Cancer: A Post Hoc Analysis of the GO2 Clinical Trial.

Morbidity After Takotsubo Syndrome: A Report From the Scottish Takotsubo Registry.

Heart Failure With Preserved Ejection Fraction Phenotype Is Associated With Early Symptom Onset in Aortic Stenosis and Residual Symptoms After Transcatheter Aortic Valve Implantation.

Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial.